Special Report: Many Expensive New Cancer Drugs Are Useless (or Worse)

Bottom Line, July 3 2017: Many new cancer drugs are costly but aren’t proven to help patients live longer or improve their quality of life. We and other experts worry that fast FDA approvals are based on questionable evidence. Some drugs have serious side effects and don’t improve survival, yet they remain on the market for years, harming patients and costing patients and our healthcare system billions of dollars.

Read More »